Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Susceptibility

Antimicrobial Susceptibility of Haemophilus influenzae in the Respiratory Tracts of Patients with Cystic Fibrosis

Lieke V. M. Möller, Annette G. Regelink, Henny Grasselier, Loek van Alphen, Jacob Dankert
Lieke V. M. Möller
Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam, and
Department of Medical Microbiology, University Hospital Groningen and Laboratory for Public Health, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annette G. Regelink
Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henny Grasselier
Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loek van Alphen
Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob Dankert
Department of Medical Microbiology, University of Amsterdam, Academic Medical Center, Amsterdam, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.42.2.319
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We analyzed the antimicrobial susceptibilities of Haemophilus influenzae isolates from 157 sputum specimens prospectively collected from 39 cystic fibrosis (CF) patients during a 2-year study. These isolates were characterized by random amplified polymorphic DNA analysis and major outer membrane protein (MOMP) analysis to identify H. influenzae strains and MOMP variants and to assess their persistence in the respiratory tract. Among the 247H. influenzae isolates, 16 (6.5%) produced β-lactamase. The 231 β-lactamase-negative isolates represented 85H. influenzae strains, 61 MOMP variants derived from 27 of these strains, and 85 persistent isolates identical to strains or MOMP variants. All β-lactamase-negative isolates were tested for susceptibility to ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefotaxime, cefaclor, imipenem, tetracycline, and trimethoprim-sulfamethoxazole by disk diffusion testing. Eleven (13%)H. influenzae strains, 18 (30%) MOMP variants, and 30 (35%) persistent isolates were resistant to one or more of the antibiotics tested. Antimicrobial susceptibility was decreased among MOMP variants and persistent isolates compared to nonpersistentH. influenzae strains, and changes in susceptibility occurred irrespective of MOMP variation. We conclude that the decreased antimicrobial susceptibility of H. influenzae during persistence contributes to the poor eradication of H. influenzae from the respiratory tracts of CF patients.

Nonencapsulated Haemophilus influenzae, although a commensal of the upper respiratory tracts of healthy persons, is an important cause of acute, recurrent, and persistent infections of the human respiratory tract (28). These infections include lower respiratory tract infections of patients with cystic fibrosis (CF) (10, 17, 19).

Data on the antimicrobial susceptibility of H. influenzae isolates obtained from CF patients are limited. McCarthy et al. (15) have reported β-lactamase-mediated antimicrobial resistance to ampicillin of H. influenzaeisolates collected from sputa of CF patients during a 4-year study. However, the persistence of H. influenzae strains was not assessed in this study. Later on, by using random amplified polymorphic DNA (RAPD) analysis as a method for genotypic characterization (29) and major outer membrane protein (MOMP) analysis for phenotypic characterization of H. influenzae (19), it was found that H. influenzae strains and their MOMP variants apparently coexisted in the respiratory tracts of CF patients. Recently, it was reported that these H. influenzae strains persisted for periods of up to at least 2 years despite extensive antimicrobial treatment with various antibiotics including β-lactam antibiotics. During the persistence of H. influenzae strains, multiple MOMP variants were frequently isolated from CF patients (19).

In this study, we determined the antimicrobial susceptibilities of 247H. influenzae isolates, obtained from 39 CF patients during a 2-year follow-up study, to ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefotaxime, cefaclor, imipenem, tetracycline, and trimethoprim-sulfamethoxazole. We assessed whether MOMP variation within an H. influenzae strain affects antimicrobial susceptibility and whether the susceptibilities of persistent strains change over time. In addition, we compared the susceptibilities of persistent isolates and nonpersistent strains without MOMP variation.

MATERIALS AND METHODS

Patients.Forty CF patients (17 females and 23 males) with a history of H. influenzae infections who were attending the Academic Medical Center or the Free University Hospital in Amsterdam from 1 May 1990 to 1 January 1991 were included in a 2-year follow-up study. Patients visited either the outpatient department or were admitted to the hospital. The study population consisted of 10 children, 17 adolescents, and 13 adults. The diagnosis of CF was based on a sweat chloride concentration of >70 mmol/liter. The ages of the patients ranged from 0.2 to 36 years (median age, 13 years). The occurrence of exacerbations was recorded throughout the study. Exacerbations were defined as increased sputum production coinciding with a change in the volume and appearance of the sputum in combination with clinical symptoms such as increased cough, fever, weight loss, and decreased exercise tolerance. Patients with an exacerbation received either antibiotic treatment at home or in the hospital, usually for 2 to 3 weeks. The duration of treatment following an exacerbation is determined by the improvement of spirometric indices to previous levels or to a plateau level. Empiric treatment consisted usually of 1- to 2-week courses of various intravenously administered antibiotics followed by orally given antibiotics for 1 to 2 weeks. The choice of the antibiotics was determined by the sensitivity pattern of bacterial isolates obtained from sputum cultures before or during an exacerbation.

Examination of sputum specimens and isolation of H. influenzae.A total of 477 sputum specimens were collected in sterile vials at routine outpatient visits or on admission to the hospital. All sputa were expectorated under the supervision of a physiotherapist. In addition, 77 “gagged” sputa were obtained from nine nonexpectorating children after forced coughing induced by a throat swab (19). The median number of sputum specimens per patient was 10.5 (range, 3 to 35). Sputa were stored at 4°C within 30 min of collection. A sputum specimen was washed twice in phosphate-buffered saline (pH 7.2) and was microscopically examined within 4 h. The Gram stain was used to exclude sputa contaminated with oropharyngeal flora. H. influenzae was isolated by using selective media includingN-acetyl-d-glucosamine medium (18) and was identified by its growth requirement for hemin (X factor) and NAD (V factor) (3). Capsular polysaccharide typing was performed with the coagglutination test (5).

MOMP and RAPD analyses of H. influenzae isolates and strain definitions.Based on previous results (19), a value of 20 individual H. influenzae colonies per sputum specimen appeared to be representative for detecting the presence of multiple H. influenzae strains and/or MOMP variants in the lower respiratory tracts of CF patients. Thus, 20 individual H. influenzae isolates obtained as single colonies from primary culture media were phenotypically characterized by MOMP analysis as described previously (9, 19). Whole-cell preparations of H. influenzae isolates showing differences in the locations of MOMP P2 (molecular weight, 39,000 to 42,000) and/or P5 (molecular weight, 37,000 to 39,000) on a sodium dodecyl sulfate-polyacrylamide gel 10 cm in length after protein staining were regarded as distinct. Isolates with distinct MOMP patterns were further genotypically characterized by RAPD analysis to discriminate H. influenzae strains from MOMP variants (29). In short, genomic DNA was amplified with random primers ERIC1R and ERIC2. PCR was performed at an extension temperature of 74°C (4 min) for 35 cycles. One H. influenzaestrain was used as a reference strain for each PCR run.

H. influenzae strains are strains with unique MOMP and RAPD compositions since they differ in both their MOMP and RAPD patterns, whereas MOMP variants differ only in their MOMP patterns, not in their RAPD patterns (19, 29). H. influenzae strains with identical MOMP patterns obtained from various sputum specimens always showed identical RAPD patterns (19). We assumed that the first isolate of H. influenzae isolates with an identical RAPD pattern but showing variation in MOMP pattern was the original strain from which MOMP variants were derived (19). An H. influenzaestrain or MOMP variant reisolated from respiratory tract specimens at least 1 month after isolation of a previous strain or MOMP variant with identical RAPD and MOMP patterns was regarded as being persistent.

Determination of β-lactamase activity. H. influenzae isolates were tested for β-lactamase activity by the chromogenic cephalosporin test with nitrocephin as the substrate (22).

Antimicrobial susceptibility testing.The disk diffusion susceptibility test for H. influenzae was performed on standard haemophilus test medium (diameter, 9 cm; Becton Dickinson, Erembodegem, Belgium) as described by Doern et al. (7).H. influenzae isolates were cultured on chocolate agar medium, supplemented with 10 μg of hemin (X factor) and 10 μg of NAD (V factor) per ml at 37°C in air enriched with 5% CO2 for 18 h. Slowly growing isolates were incubated for another 18 h. A bacterial suspension was prepared in phosphate-buffered saline (pH 7.2) corresponding in density to McFarland standard 0.5. This suspension yielded 1.6 × 108 to 8 × 108 CFU/ml, as determined by colony counting. Antimicrobial susceptibility was tested with Sensi-discs (Becton Dickinson), according to the method described by National Committee for Clinical Laboratory Standards (NCCLS) standard M2-A4 (20). The antibiotics included ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefotaxime, cefaclor, imipenem, tetracycline, and trimethoprim-sulfamethoxazole. Zones of inhibition were measured to the nearest millimeter on single trials. Results were interpreted by using the criteria contained in NCCLS standard M2-A4 (20).

Statistics.Statistical analysis of antimicrobial susceptibility for various groups of non-β-lactamase-producingH. influenzae strains was performed by a chi-square analysis. P values of <0.05 were considered significant.

RESULTS

In total, 247 nonencapsulated H. influenzaeisolates were obtained from 157 of 554 (28.3%) sputum specimens from 39 CF patients. Similar results have been described previously (19). The sputum cultures of 1 CF patient remainedH. influenzae negative. The H. influenzae isolates represented 94 H. influenzaestrains and 66 MOMP variants derived from 30 of these strains. A total of 87 isolates identical to 11 H. influenzae strains and 38 MOMP variants were persistent. H. influenzaestrains from all CF patients were distinct, except for those from two pairs of siblings; the two children of each pair had MOMP variants of the same H. influenzae strain, but the strains of each pair were different.

Sixteen of the 247 (6.5%) H. influenzae isolates obtained from eight patients produced β-lactamase. These β-lactamase-producing isolates consisted of nine H. influenzae strains, five MOMP variants, and two persistent isolates identical to two MOMP variants. All β-lactamase-producingH. influenzae isolates were susceptible to amoxicillin-clavulanic acid, cefuroxime, cefotaxime, and imipenem. Eight isolates were intermediate or resistant to one or more of the antibiotics cefaclor, tetracycline, and trimethoprim-sulfamethoxazole. All β-lactamase-producing H. influenzae isolates were resistant to ampicillin. The number of β-lactamase-producingH. influenzae isolates was too low for further comparisons.

Susceptibility testing was performed on all 231 non-β-lactamase-producing H. influenzae isolates. These isolates represented 85 H. influenzae strains and 61 MOMP variants derived from 27 of these strains. A total of 85 isolates identical to 11 H. influenzae strains and 36 MOMP variants were persistent. The susceptibilities to ampicillin, amoxicillin-clavulanic acid, cefaclor, cefuroxime, cefotaxime, imipenem, tetracycline, and trimethoprim-sulfamethoxazole are shown in Table 1. In total, 47 of 231 (20%)H. influenzae isolates were intermediate or resistant to one or more of the β-lactam antibiotics ampicillin, amoxicillin-clavulanic acid, cefuroxime, and cefaclor.

View this table:
  • View inline
  • View popup
Table 1.

Antimicrobial susceptibilities of all 231 non-β-lactamase-producing H. influenzae isolates compared to 85 H. influenzae strains obtained from 39 CF patients during a 2-year follow-up study

The 231 non-β-lactamase-producing H. influenzaeisolates were further analyzed to compare antimicrobial susceptibilities among H. influenzae strains (different RAPD and MOMP patterns), MOMP variants (identical RAPD and different MOMP patterns), and persistent isolates (multiple isolates of strains and/or MOMP variants). The susceptibilities of the 85 H. influenzae strains were separately analyzed to exclude the effect of MOMP variants and persistent isolates. The susceptibilities ofH. influenzae strains to the antibiotics tested are shown in Table 1. Four (5%) strains were intermediate or resistant to one or more of the β-lactam antibiotics ampicillin, amoxicillin-clavulanic acid, cefaclor, and cefuroxime.

The results presented in Table 1 revealed that the percentage of strains or isolates with decreased susceptibility (intermediate or resistant) to one or more of the antibiotics ampicillin, amoxicillin-clavulanic acid, cefaclor, and cefuroxime was 4 times higher for the 231 H. influenzae isolates (20%) than for the 85 H. influenzae strains (5%). In contrast, the percentages of isolates and strains with decreased susceptibility to trimethoprim-sulfamethoxazole were similar (17 of 231 (7%) versus 7 of 85 (8%), respectively). These results indicate that the decreased susceptibility to β-lactam antibiotics among the 231 H. influenzae isolates is due to the presence of less-susceptible (intermediate or resistant) MOMP variants derived from susceptible strains and/or the overrepresentation of less-susceptible persistentH. influenzae isolates.

In order to analyze whether MOMP variation within a strain affects susceptibility, the susceptibilities of 61 MOMP variants were compared with the susceptibilities of their corresponding 27 H. influenzae strains obtained from 20 patients. These H. influenzae strains and their MOMP variants were all susceptible to the antibiotics cefotaxime, imipenem, and tetracycline. Eighteen (67%) H. influenzaestrains and 43 (70%) MOMP variants were susceptible to the other antibiotics tested. Decreased susceptibility was found for 18 (30%) MOMP variants derived from 8 H. influenzae strains from seven patients (Table 2). A similar frequency (30%) of decreased susceptibility was found among the 27 original H. influenzae strains and their MOMP variants. In general, most of the MOMP variants showed no changes in susceptibility compared to their original H. influenzae strains (Table 2). However, changes in the susceptibilities of MOMP variants resulted more frequently in decreased susceptibility than in increased susceptibility, compared to the susceptibilities of their original H. influenzaestrains. Furthermore, we determined whether decreased susceptibility was limited to MOMP variants or also occurred in nonpersistentH. influenzae strains without MOMP variation. Five of 47 (11%) nonpersistent H. influenzae strains without MOMP variation showed decreased susceptibility to one or more of the antibiotics tested (these strains were only resistant to trimethoprim-sulfamethoxazole and were not resistant to β-lactam antibiotics). Decreased susceptibility occurred more frequently inH. influenzae strains with MOMP variation (8 of 27) than in nonpersistent H. influenzae strains without MOMP variation (5 of 47) (χ2 = 4.3; P = 0.04). Therefore, changes in antimicrobial susceptibility occurred irrespective of MOMP variation.

View this table:
  • View inline
  • View popup
Table 2.

Antimicrobial susceptibilities of 18 MOMP variants derived from 8 original H. influenzae strains from seven patients showing decreased susceptibility to one or more of the antibiotics ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefaclor, and trimethoprim-sulfamethoxazole during a 2-year follow-up study

To determine whether changes in susceptibility are associated with persistent H. influenzae, we examined whether intermediate and resistant H. influenzae strains and their MOMP variants were overrepresented among the 231 H. influenzae isolates due to relatively more frequent isolation of these isolates over time. Therefore, the susceptibility of the first isolate of a persistent H. influenzae strain or MOMP variant was compared with those of subsequent persistent isolates. Eleven H. influenzae strains were reisolated 27 times and 36 MOMP variants were reisolated 58 times from 18 patients. All 85 persistent isolates were susceptible to the antibiotics cefotaxime, imipenem, and tetracycline. The susceptibilities of 10 of 47 (21%) first isolates were decreased for one or more of the β-lactam antibiotics, and one isolate was resistant to trimethoprim-sulfamethoxazole. Of the subsequent persistent isolates, 29 of 85 (34%) showed decreased susceptibility to one or more of the β-lactam antibiotics and 3 (4%) were resistant to trimethoprim-sulfamethoxazole.

Variation in susceptibility was observed for 12 persistent isolates of one H. influenzae strain and 28 persistent isolates of 11 MOMP variants obtained from five patients. The susceptibilities and zones of inhibition of these 52 persistent isolates for ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefaclor, and trimethoprim-sulfamethoxazole are shown in Table3. The frequency of decreased susceptibility to one or more of the antibiotics tested among persistent isolates (30 of 85) did not differ from that among the first isolates (11 of 47) (χ2 = 2.0; P = 0.16). This indicates that the first isolated H. influenzaestrains or MOMP variants and their subsequent isolates during persistence have similarly decreased susceptibilities. During antibiotic treatment of the patients, the susceptibilities of some sequentially isolated persistent H. influenzae isolates increased and some decreased over time. The cumulative duration of antibiotic treatment of the 18 patients with persistent H. influenzae isolates (623 weeks; mean, 35 ± 25 weeks) did not differ from that of 25 patients with nonpersistent H. influenzae strains without MOMP variation (656 weeks; mean 26 ± 19 weeks) (Mann-Whitney test; P = 0.14).

View this table:
  • View inline
  • View popup
Table 3.

Antimicrobial susceptibilities to ampicillin, amoxicillin-clavulanic acid, cefuroxime, cefaclor, and trimethoprim-sulfamethoxazole of 52 persistent H. influenzae isolates obtained from five CF patients at multiple time points during the 2-year follow-up study

These results suggested that persistent H. influenzaeisolates were more resistant than nonpersistent H. influenzae strains without MOMP variation. Therefore, the susceptibilities of persistent isolates and nonpersistent strains were compared. Thirty of 85 (35%) persistent isolates showed decreased susceptibility to one or more of the antibiotics tested. In contrast, 5 of 47 (11%) nonpersistent strains showed decreased susceptibility to these antibiotics (these strains were only resistant to trimethoprim-sulfamethoxazole and not resistant to β-lactam antibiotics). The frequency of decreased susceptibility was higher for persistent isolates than for nonpersistent H. influenzae strains (χ2 = 9.4; P = 0.002).

DISCUSSION

In the present study, 6.5% of the nonencapsulated H. influenzae isolates obtained from sputum specimens of 39 CF patients during a 2-year study were β-lactamase positive. A higher frequency of β-lactamase-positive strains, ranging from 8.3 to 15.6%, has been reported for H. influenzaeisolates obtained from patients with various diseases (1, 6, 11, 13, 14, 25, 26). In a study by McCarthy et al. (15), it was demonstrated that 13% of isolates from CF patients produced β-lactamase and were therefore ampicillin resistant, whereas ampicillin resistance of H. influenzae strains without β-lactamase activity was not observed. This is in contrast to the results of our study where 8.2% of β-lactamase-negativeH. influenzae isolates had decreased susceptibility to ampicillin. Higher (12.1%) as well as lower (1%) percentages of β-lactamase-negative H. influenzae isolates which were resistant to ampicillin have been reported for clinical isolates from patients with a variety of respiratory diseases (1, 6, 11, 13, 14, 25, 26). The rates of resistance to cefaclor (16.2%) and cefuroxime (5.7%) were similar to those reported by James et al. (13) for H. influenzae isolates obtained from a variety of respiratory tract specimens. It was reported that in more than 50% of cases the non-β-lactamase-mediated decreased susceptibility of H. influenzae to ampicillin was combined with resistance to cefuroxime and/or cefaclor but not to imipenem. Combined resistance to several β-lactam antibiotics has been previously reported for isolates from patients with chronic respiratory disease (12, 24). The frequency of decreased susceptibility of H. influenzae isolates to trimethoprim-sulfamethoxazole in our study (7.3%) was similar to the frequency reported by the European Study Group (14). The low percentage of resistance to tetracycline of H. influenzae strains was similar to the percentages reported in the British study (26) and in the European study (14). Decreased susceptibility to tetracycline was only found in β-lactamase-positive strains, suggesting conjugative plasmids encoding resistance to tetracycline and ampicillin. In the American study (6), resistance to tetracycline was mostly observed in combination with plasmid-mediated resistance to ampicillin and chloramphenicol.

Our collection of H. influenzae isolates was characterized by MOMP and RAPD analysis as described previously (19, 29). H. influenzae strains were shown to differ both in MOMP and RAPD patterns. MOMP variants only differing in MOMP patterns were frequently isolated from the lower respiratory tracts of CF patients. In some patients these variants persisted for many months, often concomitantly (19).

The frequency of decreased susceptibility was lower among H. influenzae strains than among all 231 H. influenzae isolates. Since one obvious reason for this result was that MOMP variants were more resistant than the strains, the susceptibilities of the strains and their MOMP variants were compared. Our analysis showed that the frequency of decreased susceptibility of MOMP variants was similar to that of strains from which MOMP variants were derived. However, H. influenzae strains giving rise to MOMP variants appeared more resistant than strains without MOMP variants. As H. influenzae strains with MOMP variation differ in susceptibility from those without MOMP variation, they should be considered as a separate population of strains. Therefore, MOMP variation may play a role in the decreased susceptibility. Variation in MOMPs of H. influenzae strains obtained from lower respiratory tract specimens of CF patients occurred mainly in MOMP P2 (19). Variation in MOMP P2 (2) and porins of other bacteria (21) have been associated with altered antibiotic susceptibility. Porins form pores through the outer membrane (27), which act as diffusion channels for small hydrophilic solutes including β-lactam antibiotics (2, 4, 21). Alternatively, as the occurrence of MOMP variation requires the persistence of H. influenzae (8, 9, 19, 30), strains with MOMP variants may have become more resistant even before the first H. influenzae isolate was obtained, i.e., before inclusion of the patient in the study. A dominant role of porin MOMP P2 variation in decreased susceptibility is not very likely, since persistent isolates without variation in MOMP patterns showed similar frequencies of decreased susceptibility. Therefore, we favor the hypothesis that decreased susceptibility to antibiotics, especially β-lactam antibiotics, is mainly associated with persistentH. influenzae in the lower respiratory tracts of CF patients. Interestingly, decreased susceptibility to β-lactam antibiotics was mainly confined to four H. influenzaestrains (strains 66, 67, 70, and 77) and their MOMP variants isolated from four patients during persistence, suggesting that the conditions in the respiratory tracts of these patients favor selection of less-susceptible strains. It appeared that the first isolated strains which persisted were already resistant at the time of isolation from sputum specimens. No relationship to antibiotic treatment was found since the duration of antibiotic treatment during the study did not differ among the 18 patients with persistent H. influenzae isolates and the 25 patients with nonpersistentH. influenzae strains without MOMP variation.

Antimicrobial susceptibility changed during the persistence ofH. influenzae strains and MOMP variants. Despite antibiotic therapy, both a decrease and an increase in the susceptibilities of persistent isolates over time were observed. Although these strains and variants persisted, they were not always recovered from each consecutive sputum specimen. Antibiotic therapy probably reduces the load of certain susceptible H. influenzae strains, while other strains are allowed to persist in the respiratory tract. However, no evidence was found for the gradual increase of resistance among longitudinally obtained H. influenzae isolates even after extensive antibiotic treatment (19). It is suggested that selection mechanisms resulting in less-susceptible isolates during persistence are rather ineffective. Other factors such as the low level of penetration of antibiotics into the viscous sputum may also be responsible for the poor eradication ofH. influenzae from the respiratory tracts of CF patients (23).

Changes in susceptibility to β-lactam antibiotics as well as to other antibiotics were not associated with MOMP P2 variation. Non-β-lactamase-mediated resistance to β-lactam antibiotics may be due to alterations in target proteins for these antibiotics such as penicillin-binding proteins (16). The MOMP P2 variation is therefore most likely antigenic variation, occurring under strong immunological pressure during persistence of H. influenzae as previously reported (8, 30).

In conclusion, decreased antimicrobial susceptibility of non-β-lactamase-producing H. influenzae isolates occurred more frequently among MOMP variants and persistent strains than among nonpersistent strains. Changes in the susceptibilities of persistent H. influenzae strains in the respiratory tracts of CF patients occurred irrespective of MOMP variation.

ACKNOWLEDGMENTS

We are grateful to B. C. Meijer (Laboratory for Public Health, Groningen) for helpful criticism and statistical assistance.

A. Regelink was financially supported by the Netherlands Asthma Foundation (grant 92.28).

FOOTNOTES

    • Received 3 March 1997.
    • Returned for modification 19 July 1997.
    • Accepted 26 November 1997.
  • Copyright © 1998 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Bajanca-Lavado M. P.,
    2. Casin I.,
    3. Vaz Pato M. V.,
    4. The Multicentre Study Group
    Antimicrobial resistance and epidemiological study of Haemophilus influenzae strains isolated in Portugal. J. Antimicrob. Chemother. 38 1996 615 625
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Burns J. L.,
    2. Smith A. L.
    A major outer-membrane protein functions as a porin in Haemophilus influenzae. J. Gen. Microbiol. 133 1987 1273 1277
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Campos J. M.
    Haemophilus Manual of clinical microbiology 6th ed. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. 1995 556 565 ASM Press Washington, D.C
  4. 4.↵
    1. Coulton J. W.,
    2. Mason P.,
    3. Dorrance D.
    The permeability barrier of Haemophilus influenzae type b against β-lactam antibiotics. J. Antimicrob. Chemother. 12 1983 435 449
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Dirks-Go S. I. S.,
    2. Zanen H. C.
    Latex agglutination, counter immunoelectrophoresis and protein A coagglutination in diagnosis of bacterial meningitis. J. Clin. Pathol. 31 1978 1167 1171
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Doern G. V.,
    2. Jorgensen J. H.,
    3. Thornsberry C.,
    4. Preston D. A.,
    5. Tubert T.,
    6. Redding J. S.,
    7. Maher L. A.
    National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob. Agents Chemother. 32 1988 180 185
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Doern G. V.,
    2. Gerlach E. H.,
    3. Jorgensen J. H.,
    4. Murray P. R.,
    5. Thornsberry C.,
    6. Washington J. A. Jr.
    Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn. Microbiol. Infect. Dis. 14 1991 485 493
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Duim B.,
    2. van Alphen L.,
    3. Eijk P. P.,
    4. Jansen H. M.,
    5. Dankert J.
    Antigenic drift of non-encapsulated Haemophilus influenzae major outer membrane protein P2 in patients with chronic bronchitis is caused by point mutations. Mol. Microbiol. 11 1994 1181 1189
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Groeneveld K.,
    2. van Alphen L.,
    3. Eijk P. P.,
    4. Jansen H. M.,
    5. Zanen H. C.
    Changes in outer membrane proteins of nontypeable Haemophilus influenzae in patients with chronic obstructive pulmonary disease. J. Infect. Dis. 158 1988 360 365
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Hoiby N.
    Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis. Acta Pathol. Microbiol. Scand. 82 1974 541 550
    OpenUrl
  11. 11.↵
    1. Hussey G.,
    2. Hitchcock J.,
    3. Hanslo D.,
    4. Coetzee G.,
    5. van Schalkwyk E.,
    6. Pitout J.,
    7. Schaaf H.
    Serotypes and antimicrobial susceptibility of Haemophilus influenzae. J. Antimicrob. Chemother. 34 1994 1031 1036
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. James P. A.,
    2. Hossain F. D.,
    3. Lewis D. A.,
    4. White D. G.
    β-lactam susceptibility of Haemophilus influenzae strains showing reduced susceptibility to cefuroxime. J. Antimicrob. Chemother. 32 1993 239 246
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. James P. A.,
    2. Lewis D. A.,
    3. Jordens J. Z.,
    4. Cribb J.,
    5. Dawson S. J.,
    6. Murray S. A.
    The incidence and epidemiology of β-lactam resistance in Haemophilus influenzae. J. Antimicrob. Chemother. 37 1996 737 746
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Kayser F. H.,
    2. Morenzoni G.,
    3. Santanam P.
    The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae. Eur. J. Clin. Microbiol. Infect. Dis. 9 1990 810 817
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. McCarthy V. P.,
    2. Wu T. C.,
    3. Hubbard V. S.
    Ampicillin-resistant Haemophilus influenzae from patients with cystic fibrosis. Am. J. Dis. Child. 137 1983 802 803
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Mendelman P. M.,
    2. Chaffin D. O.,
    3. Stull T. L.,
    4. Rubens C. E.,
    5. Mack K. D.,
    6. Smith A. L.
    Characterization of non-β-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26 1984 235 244
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Möller L. V. M.,
    2. Ruijs G. J.,
    3. Heijerman G. M.,
    4. Dankert J.,
    5. van Alphen L.
    Haemophilus influenzae is frequently detected with monoclonal antibody 8BD9 in sputum samples from patients with cystic fibrosis. J. Clin. Microbiol. 30 1992 2495 2497
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Möller L. V. M.,
    2. van Alphen L.,
    3. Grasselier H.,
    4. Dankert J.
    N-acetyl-d-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis. J. Clin. Microbiol. 31 1993 1952 1954
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Möller L. V. M.,
    2. Regelink A. G.,
    3. Grasselier H.,
    4. Dankert-Roelse J.,
    5. Dankert J.,
    6. van Alphen L.
    Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis. J. Infect. Dis. 172 1995 1388 1392
    OpenUrlCrossRefPubMed
  20. 20.↵
    National Committee for Clinical Laboratory Standards Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A4. 1992 National Committee for Clinical Laboratory Standards Villanova, Pa
  21. 21.↵
    1. Nikaido H.
    Role of permeability barriers in resistance to β-lactam antibiotics. Pharmacol. Ther. 27 1985 197 231
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. O’Callaghan C. H.,
    2. Morris A.,
    3. Kirby S. M.,
    4. Shingler A. H.
    Novel method for detection of β-lactamases by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1 1972 283 288
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Pennington J. E.
    Penetration of antibiotics into respiratory secretions. Rev. Infect. Dis. 3 1981 67 73
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Powell M.,
    2. Livermore D. M.
    Selection and transformation of non-β-lactamase-mediated insusceptibility to β-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents. J. Antimicrob. Chemother. 26 1990 741 747
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Powell M.,
    2. McVey D.,
    3. Kassim M. H.,
    4. Chen H. Y.,
    5. Williams J. D.
    Antimicrobial susceptibility of Streptococcus pneumoniae,Haemophilus influenzae and Moraxella (Branhamella) catarrhalis isolated in the UK from sputa. J. Antimicrob. Chemother. 28 1991 249 259
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Powell M.,
    2. Fah Y. S.,
    3. Seymour A.,
    4. Yuan M.,
    5. Williams J. D.
    Antimicrobial resistance in Haemophilus influenzae from England and Scotland in 1991. J. Antimicrob. Chemother. 29 1992 547 554
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Srikumar R.,
    2. Dahan D.,
    3. Gras M. F.,
    4. Ratcliffe M. J. H.,
    5. van Alphen L.,
    6. Coulton J. W.
    Antigenic sites on porin of Haemophilus influenzae type b: Mapping with synthetic peptides and evaluation of structure predictions. J. Bacteriol. 174 1992 4007 4016
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Turk D. C.
    The pathogenicity of Haemophilus influenzae. J. Med. Microbiol. 18 1984 1 16
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    1. Van Belkum A.,
    2. Duim B.,
    3. Regelink A.,
    4. Möller L.,
    5. Quint W.,
    6. van Alphen L.
    Genomic DNA fingerprinting of clinical Haemophilus influenzae isolates by polymerase chain reaction amplification: comparison with major outer-membrane protein and restriction fragment length polymorphism analysis. J. Med. Microbiol. 41 1994 63 68
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Vogel L.,
    2. Duim B.,
    3. Geluk F.,
    4. Eijk P.,
    5. Jansen H.,
    6. Dankert J.,
    7. van Alphen L.
    Immune selection for antigenic drift of major outer membrane protein P2 of Haemophilus influenzae during persistence in subcutaneous tissue cages in rabbits. Infect. Immun. 64 1996 980 986
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Antimicrobial Susceptibility of Haemophilus influenzae in the Respiratory Tracts of Patients with Cystic Fibrosis
Lieke V. M. Möller, Annette G. Regelink, Henny Grasselier, Loek van Alphen, Jacob Dankert
Antimicrobial Agents and Chemotherapy Feb 1998, 42 (2) 319-324; DOI: 10.1128/AAC.42.2.319

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antimicrobial Susceptibility of Haemophilus influenzae in the Respiratory Tracts of Patients with Cystic Fibrosis
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antimicrobial Susceptibility of Haemophilus influenzae in the Respiratory Tracts of Patients with Cystic Fibrosis
Lieke V. M. Möller, Annette G. Regelink, Henny Grasselier, Loek van Alphen, Jacob Dankert
Antimicrobial Agents and Chemotherapy Feb 1998, 42 (2) 319-324; DOI: 10.1128/AAC.42.2.319
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
cystic fibrosis
Haemophilus influenzae
Respiratory System

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596